XenoGesis has been working with biopharmaceutical company Sitryx to support the discovery of novel targets and the development of innovative therapies for autoimmune and inflammatory disease in the fast-emerging area of immunometabolism. Sitryx turned to XenoGesis for its scientific expertise and influence in solving the complex...
Amphista’s potent bifunctional small molecules augment targeted protein degradation Investors include Advent Life Sciences, the Scottish Investment Bank, the European Investment Fund and US-based BioMotiv Glasgow, Scotland, 7 April 2020 – Amphista Therapeutics, a biopharmaceutical company creating first-in-class cancer therapeutics that harness the body’s natural processes...
One of Nottingham’s most successful bioscience companies is working towards developing a drug to help treat the deadly coronavirus. Sygnature Discovery, which moved into BioCity in Nottingham city centre in 2004, provides drug discovery and pre-clinical services and expertise to clients across the world. The company has more than...
Platelet Services Ltd, a contract research organisation providing pre-clinical services in platelet testing moved to BioCity Nottingham facilities in March this year. Platelet Services offers standard and customised platelet testing assays to determine the effect of compounds, or other agents, on platelet function. The company can...
The BIA is helping the UK Government (Office for Life Sciences) to raise awareness of an urgent call out to the life sciences sector to help increase the supply of antigen testing kits for COVID-19. The requirement is for commercial supply of the following: * Full testing...
– OMass acquires a pharmacology team led by industry expert, Professor Steven Charlton – Oxford, 25 February 2020 – OMass Therapeutics (“OMass”), a biotechnology company harnessing native mass spectrometry to drive drug discovery in high definition, today announced completion of the acquisition of assets and capabilities from...
BioCity are delighted to announce that we are the headline sponsor for Medilink East Midland's (EM) flagship annual event, Innovation Day. Medilink EM Innovation Day 2020 will take place on 2 July at the Nottingham Belfry (NG8 6PY) from 9 am to 5 pm. This is...
WILTON – Worn Again has advanced industry efforts to replace the use of virgin materials in textiles with the commissioning of its first pilot-scale facility that can separate, decontaminate and then extract polyester (PET) and cellulose from mixed fabric waste. The step up from the laboratory...
On Friday, 31 January 2020 the United Kingdom formally left the European Union (EU), but what does this mean for your Intellectual Property (IP) rights? Patent protection will be unaffected by Brexit as there is currently no European Union system for protecting patents and the United...
BioAscent has been shortlisted in the Business Leadership and the Rising Stars categories at this year’s Scottish Life Sciences Awards. The Business Leadership Award recognises a management team that has significantly advanced its business. BioAscent’s management team has transformed the business bringing in chemistry and biology...